Cyabra Completes Preferred Stock Exchange and Conversion, Issuing 83.5M Shares and Warrants
CYAB sits 36% above its 52-week low of $0.251.
Summary
Cyabra completed its preferred stock exchange and conversion on September 9, 2026, issuing approximately 83.5M shares and warrants at a $0.435 conversion price — a massive dilution event for a company with a $6M market cap.
Key Events · Financing and Capital Events · CYAB
-
Preferred Stock Exchange and Conversion Closed
On September 9, 2026, Cyabra closed the Exchange Agreement and Conversion Agreement after receiving stockholder approval on September 2, 2026.
-
83.5M Shares and Warrants Issued
Series C Preferred Shares were exchanged for 24.5M pre-funded warrants, 24.5M Series A warrants, and 24.5M Series B warrants at $0.4349 per share. Series A and Series B Preferred Shares were converted into 9.76M common shares and a pre-funded warrant for 25.0M shares.
-
Conversion Price Reduced to $0.435
The conversion price for Series A and Series B Preferred Shares was reduced to $0.435 per share, and anti-dilution protections were removed from the Certificates of Designation.
-
Massive Dilution Overhang
The 83.5M shares and warrants issued represent a massive increase in potential common stock outstanding relative to Cyabra's $6M market cap, creating significant dilution risk for existing holders.
Analysis · CYAB · Technology
Cyabra closed its previously announced preferred stock exchange and conversion transactions on September 9, 2026, after receiving stockholder approval on September 2. The Series C Preferred Shares were exchanged for 24.5M pre-funded warrants, 24.5M Series A warrants, and 24.5M Series B warrants at $0.4349 per share. Separately, 35.6M Series A and Series B Preferred Shares were converted into 9.76M common shares and a pre-funded warrant for 25.0M shares. The conversion price was reduced to $0.435 and anti-dilution protections were removed. This is the expected follow-through to the July 10, 2026 8-K and July 31, 2026 proxy, but the specific share and warrant counts are newly disclosed and represent a massive increase in potential common stock outstanding — roughly 83.5M shares and warrants combined, against a company with a market cap of only $6M. The removal of anti-dilution protections and the low conversion price relative to the current $0.342 stock price create significant overhang and dilution risk for existing holders.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.8% of the 1864 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CYAB was trading at $0.34 on NASDAQ in the Technology sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.25 to $14.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.